Device Trial Radar · NCT05480215
Symptomatic Relief of Action Tremor With Cala Trio Using Trio+ Bands
Last checked: Nov 19, 2026Latest source record: Jul 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Oct 7, 2021
Primary completion
Dec 16, 2021
Study completion Dec 16, 2021
Sponsor
- Lead sponsor
- Cala Health, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 29, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Demonstrate safety and effectiveness of symptomatic action tremor relief in the treated hand following stimulation with the Cala Trio System using the Trio+ bands as compared to the Trio bands in adults with Essential Tremor (ET) and/or Parkinson's Disease (PD) over 2 weeks.
Conditions
- Essential Tremor
- Parkinson Disease
Interventions
Cala DeviceDevice
transcutaneous afferent patterned stimulation (TAPS)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Tremor power changes from pre-stimulation to post-stimulationTime frame: baseline, pre-intervention and immediately after the intervention
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Cala Clinic
San Mateo, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.